Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-07-18
1993-09-28
Chan, Y. Christina
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 514 17, 514 58, 514885, 514863, 514966, 514970, 530328, 530329, 530330, 930 21, 930DIG803, A61K 3702, C07K 706
Patent
active
052486672
ABSTRACT:
Peptides previously disclosed as useful for preventing HIV from binding to cell binding sites have now been shown to have thymoleptic qualities and to be useful for tretment of psoriasis in patients who lack antibodies against HIV.
REFERENCES:
patent: 4659696 (1987-04-01), Hirai et al.
patent: 5063206 (1991-11-01), Bridge et al.
Rudimger, Peptide Hormones, Parson (Ed.), U. Park Press, Baltimore, pp. 1-7, (1976).
Pert et al., Proc. Natl. Acad. Sci., vol. 83, pp. 9254-9258 (Dec., 1986).
Ruff et al., FEB, vol. 211, No. 1, pp. 17-22, (Jan., 1987).
Karl-Heinz Fromming, Proceedings of the First Int. Symp. on cyclodextrins Szejtli (Ed.) D. Reidel Publishing Co., Boston, pp. 367-376 (1981).
Bridge Peter
Goodwin Frederick K.
Chan Y. Christina
Spiegel Jack
The United States of America as represented by the Secretary of
LandOfFree
Method of treating psoriasis using synthetic peptide composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating psoriasis using synthetic peptide composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating psoriasis using synthetic peptide composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2190952